The rapid adoption of the Omnipod 5 answered a question automated insulin delivery system manufacturers posed for years: with ...

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...

The global Insulin Delivery Device Market, valued at US$32.6 billion in 2024 stood at US$35.3 billion in 2025 and is ...

How TIME and Statista Determined the World's Most Sustainable Companies of 2025 In the fight against climate change, companies are navigating ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...

She went on to demand that all insulin manufacturers, Sanofi included, ensure that insulin pens are made available at a price point of $1 each, asserting, “The time has come to end profiteering ...

Insulin Pen Market Insulin Pen Market Dublin, March 07, 2025 (GLOBE NEWSWIRE) -- The "Insulin Pen Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been ...

Novo Nordisk A/S and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human insulin pen market. South Africa’s Competition ...

South Africa’s competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive practices in the human insulin pen market, the authority said on Tuesday.

Sanofi also chose not to respond to the government tender seeking bids to supply insulin pens, according to Doctors Without Borders, also known as MSF. The lack of a bulk buying agreement forced South ...